22
Participants
Start Date
January 17, 2011
Primary Completion Date
March 6, 2013
Study Completion Date
March 6, 2013
BMN 701
GILT-tagged recombinant human GAA
Royal Adelaide Hospital, SA Pathology, Adelaide
University of Florida College of Medicine, Gainesville
Zentrum für Kinder- und Jugenmedizin, Mainz
University of Kansas Medical Center, Kansas City
Hôpital Pitié-Salpêtrière, Paris
Univ of California San Diego School of Medicine, La Jolla
Hôpital de I´Archet- Centre Hospitalier Universitaire Nice, Nice
Old Queen Elizabeth Hospital, Department of Medicine, Birmingham
Royal Free Hospital, London
Salford Royal Hospital NHS Trust, Salford
Lead Sponsor
BioMarin Pharmaceutical
INDUSTRY